Menopausal Hot Flashes Market Investigation and Growth Forecasted Until the End of 2022

Posted on 2019-07-16 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, USA, 2019-Jul-16 — /EPR Network/ —Market Research Reports Search Engine (MRRSE) has recently updated its massive research catalog by adding a new study, titled “Menopausal Hot Flashes Market”. The study offers a clear insight about the prevailing trends and innovations happening in the Menopausal Hot Flashes Market. Readers can further access details about research highlights and executive summary to gain a better idea about this assessment. The market overview covers key industry developments and market opportunity map during the mentioned forecast period. In addition, a holistic view of the entire global market scenario across all the prime regional segments, such as (Regions) has been delivered.

Request a Sample Report or View Summary of Report @ https://www.mrrse.com/sample/1504

The global menopausal hot flashes market is fragmented moderately. The top eight players in the market collectively held a share of more than 50% in 2014. Novartis AG and Pfizer Inc., are the top two players within the market, accounting for nearly 30% of the market in 2014, states a new research study by MRRSE. Pfizer is likely to benefit from its well established presence across North America whereas Novartis is gaining on account of its efforts directed towards expanding its product portfolio for the treatment of menopausal hot flashes.

According to the report by MRRSE, the global menopausal hot flashes market will be worth US$5.28 bn by the end of the forecast period. On the basis of therapy, the demand for non-hormonal therapies for menopausal hot flashes is increasing. On the basis of geography, North America is leading on account of the rising incidence of menopausal vasomotor symptoms. Asia Pacific is anticipated to one of the most lucrative regional markets on account of the rising awareness among the population regarding menopause-related health issues. Initiative

s taken by Governments to Increase Awareness Level Driving Demand

According to a MRRSE analyst, “the increasing incidences of women suffering from hot flashes, night sweats on account of menopause is a key factor boosting the growth of this market.” Governments across the globe are taking several initiatives to create awareness among women regarding women’s health after menopause. There are several private healthcare institutes which are also focusing on creating awareness and providing effective care and treatment for menopausal hot flashes.

Speedy Approval of New Drugs Boosting Growth of Market

A key factor boding well for the market is the speedy approval of several new drugs or therapeutics for menopausal hot flashes. This is also working well for market players as its is helping create new avenues of growth. The market is also benefitting from the rise in the number of working women and the growing importance of career for women, leading to a higher ability to spend on treatment and rise in demand for several hygiene products and treatment solutions for menopausal symptoms so as to be able to carry out their professional duties and responsibilities. As an increasing number of women worldwide are realizing that getting effective menopausal treatment boosts good health, self-confidence, self-esteem, and overall quality of life, the demand for these drugs will soar high.

The report also profiles major players in the global menopausal hot flashes market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Allergan plc, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Merck & Co. Inc., Novartis International AG, Novo Nordisk, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.

Complete Report Details with Tables and Figures @ https://www.mrrse.com/menopausal-hot-flashes

The global menopausal hot flashes market is segmented as follows:

Global Menopausal Hot Flashes Market, by Therapy Type

Hormonal
- Estrogen
  - Premarin
  - Vivelle-Dot
- Progestin
  - Prometrium
- Combination Therapy
  - Duavee
  - Prempro
- Non-Hormonal
  - Brisdelle

Global Menopausal Hot Flashes Market, Pipeline Analysis

Phase I and II Drugs
Phase III Drugs

Global Menopausal Hot Flashes Market, by Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Rest of Europe
Asia Pacific
- Australia
- Japan
- India
- China
- Rest of Asia Pacific
Rest of the World
- Latin America
- Middle East and Africa

Send an Inquiry @ https://www.mrrse.com/enquiry/1504

About Market Research Reports Search Engine (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Matched content

Editor’s pick